Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of IDP-110 in patients with acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• IDP-110

Snippet

Sponsor: Dow Pharmaceutical Sciences | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED